Aggressive lipid management for cardiovascular prevention: evidence from clinical trials. - Wikidata - awgldk - TriplyDB

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

http://www.wikidata.org/entity/Q35183108

about

Achieving vascular risk factor targets: a survey of a London general practice.Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents.

P2860

Q46719224-A7CFF677-D7D3-479C-A95F-0D05A2630840 Q51900207-A741105B-9181-42DD-BD14-ACF5C9F062B7

P2860

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

http://www.wikidata.org/entity/Q35183108

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@ast

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@en

type

label

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@ast

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@en

prefLabel

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@ast

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@en

P1433

Q35183108-8EE7901B-7D7A-406D-BFFB-99063690D9F3

P1476

Q35183108-672F5A01-ACA2-44F4-B822-BE4C86277723

P2093

Q35183108-8F3C0F94-DFDF-435C-8066-455D4641C2EF

P2860

Q35183108-05A8EF6A-69A8-4AE6-9439-5A48323672E5

Q35183108-1A8490EB-A314-4A52-B7FC-BBA3C55E3193

Q35183108-1B1CE9F9-6D50-47E3-9E5C-3DD6ED76640C

Q35183108-244FB347-4A60-4989-BDFA-955C1E796960

Q35183108-460B402E-CD47-4A87-A463-927EC4EB2969

Q35183108-4E76F8A0-3F61-41F5-861E-49645F49F0C6

Q35183108-4F5A0619-D6F2-4B2E-B8BC-17116ABD70D2

Q35183108-5220BF0A-CA6B-4D46-B353-589C11130466

Q35183108-5F6FBE14-4D96-44F0-9ADE-82AD115FDE0D

Q35183108-774DD67B-4338-4822-B0F9-3C74992232F0

P304

Q35183108-48C52965-17A3-4617-A9C0-8CE16A666F63

P31

Q35183108-ACAD74EB-F824-4AAE-A03F-5EBD7751F3BC

P356

Q35183108-844B7D58-252B-4E2D-B73D-B36C66CF9BE9

P433

Q35183108-6A3C4ED3-C7AA-4CEE-8A55-2C8242CA3B60

P478

Q35183108-EF309BC2-319F-4511-A6EC-EEC18443D8AA

P577

Q35183108-BAFFD610-34BB-492E-893C-28936CCA0A0D

P698

Q35183108-84B86F81-C192-465F-8F8C-1BAC35633072

P356

15353702-0322807-01

P1433

Experimental Biology and Medicine

P1476

Aggressive lipid management for cardiovascular prevention: evidence from clinical trials.

@en

P2093

Karen E Friday

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

The interaction of diltiazem with simvastatin

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin.

P304

769-778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/15353702-0322807-01

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12876295

http://www.w3.org/2001/XMLSchema#string